SCHEMBL8761817

SCHEMBL8761817

CC(=O)c1ccccc1CCC(SCC(C)C(=O)O)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8761822 1.00 — —
SCHEMBL8760772 0.93 CYP2C8 (0.60) —
SCHEMBL8760780 0.93 CYP2C8 (0.60) —
SCHEMBL9689105 0.89 — —
SCHEMBL9691021 0.88 MEN1 (0.75) —
SCHEMBL9689095 0.88 MEN1 (0.75) —
SCHEMBL9690891 0.88 MEN1 (0.75) —
SCHEMBL12596747 0.86 CYSLTR1 (0.66) —
SCHEMBL10014498 0.85 — —
SCHEMBL8761836 0.85 CYSLTR1 (0.82) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0500360-B1 Quinoline-containing ketoacids as leukotriene antagonists MERCK FROSST CANADA INC (CA) 1997-06-25 — — EP claimed
EP-0500360-B1 Quinoline-containing ketoacids as leukotriene antagonists MERCK FROSST CANADA INC (CA) 1997-06-25 — — EP disclosed
EP-0500360-A1 Quinoline-containing ketoacids as leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1992-08-26 — — EP disclosed
Send feedback